Emergency Medicine Doctors in Saint Peters, MO Accepting Medicare

8 Emergency Medicine doctors found. Showing 1 - 8

Joy Stowell, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6994 Mexico Rd, Saint Peters, MO 63376 Phone: 636-397-3231

Heather Webb, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 636-916-9000

George Mekhjian, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 636-916-9000    Fax: 314-317-0606

Mr. Jonathan Jude Reed, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 314-525-1900    Fax: 314-525-4868

Jeffrey Schwartz, M.D., FACEP Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 636-916-9000

Scott Landry, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 636-916-9000

Jose Marino Parra, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 Bjc Saint Peters Dr, Ste. 200, Saint Peters, MO 63376 Phone: 636-916-9615    Fax: 636-916-9850

Dr. David A Poggemeier, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 636-916-9640

News Archive

Alexion Pharmaceuticals reports interim results from phase 1 trial on samalizumab antibody

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced the presentation of interim results from the first Phase I/II trial of samalizumab, the company's investigational, first-in-class humanized monoclonal antibody.

Novel device can benefit patients with upper limb paralysis

A tiny device the size of a small paperclip has been shown to help patients with upper limb paralysis to text, email and even shop online in the first human trial.

Novel personalized therapy could treat metastatic melanoma and metastatic synovial cell sarcoma

Researchers have found that a novel form of personalized therapy that genetically engineers a patient's own anti-tumor immune cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing a potentially new therapeutic approach against these and other cancers.

FDA sets new PDUFA date for AstraZeneca's ticagrelor

AstraZeneca announced today that the US Food and Drug Administration (FDA) has acknowledged receipt of the company's reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA).

Designing infectious disease forecasting models to predict dengue epidemics

Dengue viruses are on the move. Spread among humans by mosquitoes, and across geographic boundaries through travel, the virus affects up to an estimated 390 million people every year around the world. In the U.S., recent outbreaks have occurred in Florida, Texas, Hawaii, and Puerto Rico. Scientists know one of the best ways to reduce the impact of the disease is to prepare healthcare providers by forecasting epidemics before they happen.

Read more Medical News

› Verified 4 days ago